Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90

被引:39
作者
Matokanovic, Mirela [1 ,3 ]
Barisic, Karmela [1 ]
Filipovic-Grcic, Jelena [2 ]
Maysinger, Dusica [3 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Dept Med Biochem & Hematol, HR-10000 Zagreb, Croatia
[2] Univ Zagreb, Fac Pharm & Biochem, Dept Pharmaceut, HR-10000 Zagreb, Croatia
[3] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada
关键词
Cancer; Hsp70; Chitosan; siRNA nanocarriers; Celastrol; Tumor spheroids; IN-VITRO; CHITOSAN NANOPARTICLES; RNA INTERFERENCE; TUMOR SPHEROIDS; DRUG-DELIVERY; APOPTOSIS; CELASTROL; TRANSLOCATION; MITOCHONDRIA; ACTIVATION;
D O I
10.1016/j.ejps.2013.04.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Inducers of heat shock protein 70 (Hsp70) commonly promote cancer cell viability whereas inhibitors of Hsp90 reduce it. The anticancer agent celastrol, interferes with signal transduction pathways involving these heat shock proteins. The objective of this in vitro study was to silence inducible Hsp70 and to promote celastrol-induced tumor cell death. Hsp70 siRNA loaded chitosan-TPP carriers were prepared by ionic gelation and characterized by photon correlation spectroscopy and asymmetric flow field-flow fractionation combined with dynamic light scattering. Viability of human leukemia and glioblastoma cells and Hsp70 silencing was determined following treatment with chitosan-TPP-Hsp70 siRNA particles. The results showed that silencing of Hsp70 by chitosan-TPP-Hsp70 siRNA treatment significantly reduced cell viability, and enhanced antiproliferative effects of celastrol in leukemia and glioblastoma cells. In glioblastoma spheroids, higher concentrations of celastrol and Hsp70 siRNA in chitosan-TPP nanocarriers were necessary to induce cell death. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:149 / 158
页数:10
相关论文
共 59 条
[1]   The safety of chitosan as a pharmaceutical excipient [J].
Baldrick, Paul .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2010, 56 (03) :290-299
[2]   Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome [J].
Beere, HM ;
Wolf, BB ;
Cain, K ;
Mosser, DD ;
Mahboubi, A ;
Kuwana, T ;
Tailor, P ;
Morimoto, RI ;
Cohen, GM ;
Green, DR .
NATURE CELL BIOLOGY, 2000, 2 (08) :469-475
[3]   Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways [J].
Beere, HM .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2633-2639
[4]   Chitosan-based hydrogels for controlled, localized drug delivery [J].
Bhattarai, Narayan ;
Gunn, Jonathan ;
Zhang, Miqin .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :83-99
[5]   Heat Shock Protein 90: Inhibitors in Clinical Trials [J].
Biamonte, Marco A. ;
Van de Water, Ryan ;
Arndt, Joseph W. ;
Scannevin, Robert H. ;
Perret, Daniel ;
Lee, Wen-Cherng .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (01) :3-17
[6]  
CARLSSON J, 1984, RECENT RESULTS CANC, V95, P1
[7]   Hsp72 inhibits Fas-mediated apoptosis upstream of the mitochondria in type II cells [J].
Clemons, NJ ;
Buzzard, K ;
Steel, R ;
Anderson, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (10) :9005-9012
[8]   Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery [J].
Csaba, Noemi ;
Koeping-Hoeggard, Magnus ;
Jose Alonso, Maria .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 382 (1-2) :205-214
[9]   Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles [J].
Davis, Mark E. ;
Zuckerman, Jonathan E. ;
Choi, Chung Hang J. ;
Seligson, David ;
Tolcher, Anthony ;
Alabi, Christopher A. ;
Yen, Yun ;
Heidel, Jeremy D. ;
Ribas, Antoni .
NATURE, 2010, 464 (7291) :1067-U140
[10]   Chitosan-based nanostructures: A delivery platform for ocular therapeutics [J].
de la Fuente, Maria ;
Ravina, Manuela ;
Paolicelli, Patrizia ;
Sanchez, Alejandro ;
Seijo, Begona ;
Jose Alonso, Maria .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :100-117